BG60542B2 - Water soluble composition having coccidiostatic effect - Google Patents

Water soluble composition having coccidiostatic effect

Info

Publication number
BG60542B2
BG60542B2 BG088223A BG8822389A BG60542B2 BG 60542 B2 BG60542 B2 BG 60542B2 BG 088223 A BG088223 A BG 088223A BG 8822389 A BG8822389 A BG 8822389A BG 60542 B2 BG60542 B2 BG 60542B2
Authority
BG
Bulgaria
Prior art keywords
water soluble
composition
soluble composition
coccidiostatic
effect
Prior art date
Application number
BG088223A
Other languages
Bulgarian (bg)
Inventor
Dietrich Hiller
Theopil Hornykiewytsch
Wolfgang Raether
Original Assignee
Hoechst Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Aktiengesellschaft filed Critical Hoechst Aktiengesellschaft
Publication of BG60542B2 publication Critical patent/BG60542B2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/116—Heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Polymers & Plastics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Husbandry (AREA)
  • Zoology (AREA)
  • Food Science & Technology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Detergent Compositions (AREA)
  • Cosmetics (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Light Receiving Elements (AREA)

Abstract

The invention relates to a water soluble composition having coccidiostatic effect where the active substance is of the group of N-phenyltriazene. The composition can be applied in potable water for the treatment and puphylaxy of animals. a method for the preparation of the composition, the composition of potable water which is a stable solution with pH 6 to 7 suitable for the treatment of coccidiosis and a method for its preparation are also described.
BG088223A 1988-04-28 1989-04-24 Water soluble composition having coccidiostatic effect BG60542B2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3814323A DE3814323A1 (en) 1988-04-28 1988-04-28 WATER-SOLUBLE PREPARATIONS BY COCCIDIOSTATICA

Publications (1)

Publication Number Publication Date
BG60542B2 true BG60542B2 (en) 1995-08-28

Family

ID=6353066

Family Applications (1)

Application Number Title Priority Date Filing Date
BG088223A BG60542B2 (en) 1988-04-28 1989-04-24 Water soluble composition having coccidiostatic effect

Country Status (19)

Country Link
EP (1) EP0339555B1 (en)
JP (1) JPH01313430A (en)
KR (1) KR900015740A (en)
AT (1) ATE83661T1 (en)
AU (1) AU619004B2 (en)
BG (1) BG60542B2 (en)
BR (1) BR8901913A (en)
DD (1) DD283773A5 (en)
DE (2) DE3814323A1 (en)
DK (1) DK204689A (en)
ES (1) ES2043934T3 (en)
HU (1) HU205716B (en)
IL (1) IL90098A (en)
NZ (1) NZ228898A (en)
PH (1) PH27515A (en)
PL (1) PL279153A1 (en)
PT (1) PT90387B (en)
RU (1) RU1780510C (en)
ZA (1) ZA893077B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3288132B2 (en) * 1992-06-25 2002-06-04 サントリー株式会社 Substituted 1,2,4-triazine-3,5-dione and anticoccidial composition containing the same as an active ingredient
SI3759088T1 (en) 2018-02-26 2023-07-31 AlzeCure Pharma AB Triazine derivatives for treating diseases relating to neurotrophins
GB201810668D0 (en) 2018-06-28 2018-08-15 Stiftelsen Alzecure New compounds

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3361627A (en) * 1958-06-20 1968-01-02 Harris Trust And Savings Bank Phenothiazine compositions
DE3300793A1 (en) * 1983-01-12 1984-07-12 Bayer Ag, 5090 Leverkusen Coccidiosis
DE3408924A1 (en) * 1984-03-12 1985-09-26 Hoechst Ag, 6230 Frankfurt SUBSTITUTED 2-PHENYL-HEXAHYDRO-1,2,4-TRIAZINE-3,5-DIONE, METHOD FOR THE PRODUCTION THEREOF, MEANS CONTAINING IT AND THEIR USE
EP0179583A1 (en) * 1984-10-04 1986-04-30 Merck & Co. Inc. A system for enhancing the water dissolution rate and solubility of poorly soluble drugs
DE3531919A1 (en) * 1985-09-07 1987-03-19 Hoechst Ag SUBSTITUTED 2-PHENYL-HEXAHYDRO-1,2,4-TRIAZINE-3,5-DIONE, METHOD FOR THE PRODUCTION THEREOF, MEANS CONTAINING IT AND THEIR USE

Also Published As

Publication number Publication date
DE58903076D1 (en) 1993-02-04
PT90387A (en) 1989-11-10
AU3373589A (en) 1989-11-02
RU1780510C (en) 1992-12-07
ZA893077B (en) 1989-12-27
HU205716B (en) 1992-06-29
NZ228898A (en) 1992-02-25
PL279153A1 (en) 1989-12-27
DK204689D0 (en) 1989-04-27
EP0339555A2 (en) 1989-11-02
JPH01313430A (en) 1989-12-18
KR900015740A (en) 1990-11-10
DE3814323A1 (en) 1989-11-09
EP0339555B1 (en) 1992-12-23
PH27515A (en) 1993-08-18
BR8901913A (en) 1989-11-28
EP0339555A3 (en) 1990-01-31
DK204689A (en) 1989-10-29
ATE83661T1 (en) 1993-01-15
AU619004B2 (en) 1992-01-16
ES2043934T3 (en) 1994-01-01
IL90098A (en) 1995-11-27
PT90387B (en) 1994-10-31
HUT51490A (en) 1990-05-28
DD283773A5 (en) 1990-10-24

Similar Documents

Publication Publication Date Title
EP0209689A3 (en) Use of tetrahydrobiopterins in the treatment of infantile autism
ES8603271A1 (en) Stable composition of interleukin-2.
EP0154478A3 (en) Bacterial preparations and their use
PL264392A1 (en) A microbes killing agent
NO994640D0 (en) Cough relievers
EP0203649A3 (en) Pharmaceutic composition based on diphoshonates for the treatment of the arthrosis
EP0684260A3 (en) Tissue-derived tumor growth inhibitors, methods of preparation and uses thereof.
DE3772513D1 (en) TREATMENT OF FABRIC TO IMPROVE ITS ABILITY.
DE69800859D1 (en) Use of moxonidine to treat neuropathic pain
EP0344997A3 (en) Use of phytic acid or a salt thereof as an activator of hypoxic cells and a circulatory ameliorator
NO850391L (en) PREPARATIONS FOR COSMETIC, HEALTH AND BODY CONSERVATIVE USES
ES8707488A1 (en) Biologically active ketone derivative, preparation and use.
BG46905A3 (en) Method for manufacture of polycyclic ether antibiotic
ATE183385T1 (en) LYOPILIZED EMULSION CONTAINING ACTIVE INGREDIENTS
BG60542B2 (en) Water soluble composition having coccidiostatic effect
IL115879A0 (en) A storage stable water solution for infusion containing a thrombin inhibitor
EP0276007A3 (en) Fur animal feed and a method for preparing the same
ES2001429A6 (en) Treating water to destroy pathogens
BG102416A (en) Composition containing at least sodium hydrogencarbonate, and a method for its preparation and application
GEP19971020B (en) Composition for contact lenses processing
ES8706665A1 (en) Norfloxacin salt.
MD1440G2 (en) Process of sugar-beet seeds presawing treatment
RU96124022A (en) METHOD FOR TREATING RED FLAT EXCHANGE OF MUSCULA OF THE ORAL CAVITY
OA09771A (en) Asphodelus composition for increasing white blood cell count.
SU1387399A1 (en) NUTRIENT FOR CULTIVATION OF LEPTOSPIR